Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hillman Solutions Corp.HLMN · Entity 4721 | CFO and Treasurer | September 11, 2026 | September 14, 2026 |
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hillman Solutions Corp.
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 697,090 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Purchase · Acquired 35,500 · Balance 697,090 F1: This transaction was executed in multiple trades at prices ranging from $6.915 to $7.085, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $6.915 to $7.085, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Medpace Holdings, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 987 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 32 · Balance 987 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 32 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Exercise / conversion · Disposed 32 · Balance 32 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F2: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date April 03, 2017 · Filed April 04, 2017
Section 16 reporting ended · disclosed 2017-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 92,360 |
Reported balance
After 2017-04-03 transaction · row 1
1 source rowRow 1 · 2017-04-03 · Grant · Acquired 5,124 · Balance 92,360 F1: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 40,071 |
Reported balance
After 2017-04-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-04-03 · Grant · Acquired 40,071 · Balance 40,071 F2: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 23,301 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,301 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.40 · Expires 2025-08-31 | Direct | 55,020 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 55,020 F4: Option becomes exercisable in three equal annual installments, commencing 8/31/2018. |
| Common StockSEC Table I · non-derivative | Direct | 9,966.1892 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,966.1892 |
| Common Stock (pep)SEC Table I · non-derivative | Direct | 5,661.1892 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,661.1892 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.
F2: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option becomes exercisable in three equal annual installments, commencing 8/31/2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2023 Filed Jan 3, 2024 21:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 94 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-24-000012 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 286 | $270.72 | $77,425.92 |
DisclosureSEC source: 0000892251-23-000197 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286 Underlying: Common Stock · 286 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000147 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94 Underlying: Common Stock · 94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 94 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000147 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,782 | $0.00 Strike: $26.44 | $0.00 |
DisclosureSEC source: 0000892251-23-000113 · form4.xml · derivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,782 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 17, 2018. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,782 | $265.67 | $3,661,463.94 |
DisclosureSEC source: 0000892251-23-000113 · form4.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $265.185 to $266.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 13,782 | $26.44 | $364,396.08 |
DisclosureSEC source: 0000892251-23-000113 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000075 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188 Underlying: Common Stock · 94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 94 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000075 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,769 | $0.00 Strike: $210.88 | $0.00 |
DisclosureSEC source: 0000892251-23-000051 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769 Underlying: Common Stock · 1,769 shares Expires 2030-05-19 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:48 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000029 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:48 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 94 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000029 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 19:16 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantStock Options · Derivative | 100,369 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001822492-23-000047 · wf-form4_167838935582564.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,369 Underlying: Common Stock · 100,369 shares Expires 2033-03-07 F2 · derivative.exercise_date: Represents the grant of stock options to purchase Issuer common stock. The stock options vest in four equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 19:16 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 42,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001822492-23-000047 · wf-form4_167838935582564.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,853 F1 · security: Represents restricted stock units ("RSUs") that are a contingent right for the Reporting Person to receive one share of common stock for each RSU upon vesting. The RSUs will vest on the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer through the vesting date. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 376 | $205.77 | $77,369.52 |
DisclosureSEC source: 0001567619-22-021540 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376 Underlying: Common Stock · 376 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. F2 · derivative.expiration_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| November 30, 2022 Filed Nov 30, 2022 22:07 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | PurchaseCommon Stock | 65,000 | $7.65 | $497,380.00 |
DisclosureSEC source: 0001822492-22-000147 · wf-form4_166984601560893.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,094 F1 · price: This transaction was executed in multiple trades at prices ranging from $7.50 to $7.69, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 9,630 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-22-019121 · doc1.xml · derivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,630 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vested in multiple tranches and was fully vested on June 1, 2017. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 9,630 | $221.42 | $2,132,274.60 |
DisclosureSEC source: 0001567619-22-019121 · doc1.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $223.54. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 9,630 | $23.00 | $221,490.00 |
DisclosureSEC source: 0001567619-22-019121 · doc1.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 1,903 | $0.00 Strike: $133.87 | $0.00 |
DisclosureSEC source: 0001567619-22-011619 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903 Underlying: Common Stock · 1,903 shares Expires 2029-05-20 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 07, 2022 Filed Mar 7, 2022 18:25 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | PurchaseCommon Stock | 47,500 | $10.35 | $491,767.50 |
DisclosureSEC source: 0001822492-22-000022 · wf-form4_164667748616049.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,094 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.21 to $10.51, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2022 Filed Jan 28, 2022 23:41 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantStock Options · Derivative | 91,213 | $0.00 Strike: $9.94 | $0.00 |
DisclosureSEC source: 0001104659-22-009133 · tm224830-11_4seq1.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,213 Underlying: Common Stock · 91,213 shares Expires 2032-01-10 F2 · derivative.exercise_date: The shares underlying the option vest in four equal annual installments beginning on the first anniversary of the date of grant (which is 10 years prior to the expiration date), subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 28, 2022 23:41 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 30,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-009133 · tm224830-11_4seq1.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,594 F1 · security: Represents 30,181 restricted stock units ("RSUs") that are a contingent right to receive common stock. The RSUs will vest on the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer through the vesting date. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 1,822 | $0.00 Strike: $164.68 | $0.00 |
DisclosureSEC source: 0001567619-21-010622 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,822 Underlying: Common Stock · 1,822 shares Expires 2028-05-14 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0001567619-20-010756 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:01 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 6,472 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001567619-19-011800 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,472 Underlying: Common Stock · 6,472 shares Expires 2026-05-17 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 18, 2018 Filed May 22, 2018 20:05 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,127 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001140361-18-025169 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,127 Underlying: Common Stock · 8,127 shares Expires 2025-05-18 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 19, 2017 Filed May 23, 2017 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 13,782 | $0.00 Strike: $26.44 | $0.00 |
DisclosureSEC source: 0001140361-17-021944 · doc1.xml · derivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,782 Underlying: Common Stock · 13,782 shares Expires 2024-05-19 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 40,071 | $78.05 Strike: $78.05 | $3,127,541.55 |
DisclosureSEC source: 0001127602-17-014069 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,071 Underlying: Common Stock · 40,071 shares Expires 2024-04-03 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 5,124 | $78.05 | $399,928.20 |
DisclosureSEC source: 0001127602-17-014069 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,360 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,256 | $80.58 | $101,208.48 |
DisclosureSEC source: 0001127602-17-009769 · form4.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,966.1892 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,809 | $80.58 | $306,929.22 |
DisclosureSEC source: 0001127602-17-009769 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,222.1892 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 422 | $81.41 | $34,355.02 |
DisclosureSEC source: 0001127602-17-009241 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,413.1892 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,301 | $104.82 Strike: $104.82 | $2,442,410.82 |
DisclosureSEC source: 0001127602-16-048903 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,301 Underlying: Common Stock · 23,301 shares Expires 2023-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,100 | $104.82 | $324,942.00 |
DisclosureSEC source: 0001127602-16-048903 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,534 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| February 27, 2016 Filed Mar 1, 2016 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 422 | $97.66 | $41,212.52 |
DisclosureSEC source: 0001127602-16-044159 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421.8997 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| August 31, 2015 Filed Sep 2, 2015 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 55,020 | $102.40 Strike: $102.40 | $5,634,048.00 |
DisclosureSEC source: 0001127602-15-026475 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,020 Underlying: Common Stock · 55,020 shares Expires 2025-08-31 F3 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 8/31/2018. Read SEC document |
| August 31, 2015 Filed Sep 2, 2015 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (pep) | 5,502 | $102.40 | $563,404.80 |
DisclosureSEC source: 0001127602-15-026475 · form4.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,502 F2 · shares: Consists of Matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under its 2010 Incentive Compensation Plan. Restrictions lapse August 31, 2020. Read SEC document |
| August 31, 2015 Filed Sep 2, 2015 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,502 | $102.40 | $563,404.80 |
DisclosureSEC source: 0001127602-15-026475 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,502 F1 · shares: Purchase of shares by the reporting person pursuant to the Issuer's Partnership Equity Program under its 2010 Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.